• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载紫杉醇和拉帕替尼的双重靶向胶束用于联合治疗乳腺癌脑转移

Dual targeting micelles loaded with paclitaxel and lapatinib for combinational therapy of brain metastases from breast cancer.

机构信息

Department of Oncology, Shanghai Pudong New Area People's Hospital, Shanghai, 201200, China.

Department of Oncology, Changhai Hospital Affiliated To Navy Medical University, Shanghai, 200433, China.

出版信息

Sci Rep. 2022 Feb 16;12(1):2610. doi: 10.1038/s41598-022-06677-8.

DOI:10.1038/s41598-022-06677-8
PMID:35173243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8850478/
Abstract

Due to the presence of the blood-brain barrier (BBB), the delivery of general drugs into the brain tissue remains to be a tricky problem. For patients with brain metastases from breast cancer, drug delivery systems must overcome this physical barrier. Targeted nano vehicles arise as a promising alternative to deliver drugs to brain tissues successively. Herein, a dual targeting micelle drug delivery system loaded with paclitaxel (PTX) and lapatinib (LPTN) was developed for combinational therapy of brain metastases. In our study, it was shown the micelles modified with Angiopep-2 had high loading efficiency of paclitaxel and lapatinib (Ang-MIC-PTX/LP). In addition, Ang-MIC-PTX/LP could transport across the in vitro BBB model and accumulate in breast cancer cells. After intravenous injection, Ang-MIC significantly accumulated in the brain metastasis. Ang-MIC-PTX/LP could also extend the life span of brain metastasis mouse models. Overall, this study provided a promising method for treatment of brain metastases from breast cancer.

摘要

由于血脑屏障(BBB)的存在,将一般药物递送到脑组织仍然是一个棘手的问题。对于患有乳腺癌脑转移的患者,药物递送系统必须克服这一物理屏障。靶向纳米载体作为一种有前途的替代方法,成功地将药物递送到脑组织。在此,我们开发了一种载紫杉醇(PTX)和拉帕替尼(LPTN)的双重靶向胶束药物递送系统,用于脑转移的联合治疗。在我们的研究中,表明用 Angiopep-2 修饰的胶束具有高的紫杉醇和拉帕替尼的载药效率(Ang-MIC-PTX/LP)。此外,Ang-MIC-PTX/LP 可以穿过体外 BBB 模型并在乳腺癌细胞中积累。静脉注射后,Ang-MIC 显著在脑转移部位蓄积。Ang-MIC-PTX/LP 还可以延长脑转移小鼠模型的寿命。总的来说,这项研究为治疗乳腺癌脑转移提供了一种有前途的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/34f5ba2aa69e/41598_2022_6677_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/d0208aec7795/41598_2022_6677_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/848798da896c/41598_2022_6677_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/293c389e0839/41598_2022_6677_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/e39386477aab/41598_2022_6677_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/9875154cf664/41598_2022_6677_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/34f5ba2aa69e/41598_2022_6677_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/d0208aec7795/41598_2022_6677_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/848798da896c/41598_2022_6677_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/293c389e0839/41598_2022_6677_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/e39386477aab/41598_2022_6677_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/9875154cf664/41598_2022_6677_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5865/8850478/34f5ba2aa69e/41598_2022_6677_Fig6_HTML.jpg

相似文献

1
Dual targeting micelles loaded with paclitaxel and lapatinib for combinational therapy of brain metastases from breast cancer.载紫杉醇和拉帕替尼的双重靶向胶束用于联合治疗乳腺癌脑转移
Sci Rep. 2022 Feb 16;12(1):2610. doi: 10.1038/s41598-022-06677-8.
2
Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB.载药介孔硅纳米粒经血管穿透肽 Angiopep-2 修饰用于克服血脑屏障的脑胶质瘤靶向递药治疗
Biochem Biophys Res Commun. 2021 Jan 1;534:902-907. doi: 10.1016/j.bbrc.2020.10.076. Epub 2020 Nov 5.
3
Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.肽功能化和高载药量的新型纳米颗粒作为双重靶向药物传递系统,用于调节和控制紫杉醇向脑胶质瘤的释放。
Int J Pharm. 2018 Dec 20;553(1-2):169-185. doi: 10.1016/j.ijpharm.2018.10.022. Epub 2018 Oct 12.
4
Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.血脑屏障和胶质瘤细胞双靶向脂质体递送阿霉素和紫杉醇用于脑胶质瘤化疗的协同组合
Curr Pharm Biotechnol. 2016;17(7):636-50. doi: 10.2174/1389201017666160401144440.
5
A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro.一种新型的拉帕替尼和紫杉醇联合胶束系统,在体外对人表皮生长因子受体2阳性乳腺肿瘤具有增强的抗肿瘤作用。
J Pharm Sci. 2015 Jan;104(1):165-77. doi: 10.1002/jps.24234. Epub 2014 Nov 24.
6
Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.通过 pH 敏感聚合物胶束共递送紫杉醇和和厚朴酚来同时抑制乳腺癌的多药耐药和转移。
Acta Biomater. 2017 Oct 15;62:144-156. doi: 10.1016/j.actbio.2017.08.027. Epub 2017 Aug 30.
7
Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model.由透明质酸-紫杉醇共轭物自组装而成的载有游离紫杉醇的E-选择素结合肽修饰的胶束可抑制小鼠模型中的乳腺癌转移。
Int J Pharm. 2017 Aug 7;528(1-2):33-46. doi: 10.1016/j.ijpharm.2017.05.063. Epub 2017 May 31.
8
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.载紫杉醇的载药胶束 Angiopep 双靶向 PEG-PCL 纳米粒的抗脑胶质瘤疗效及安全性
Biomaterials. 2012 Nov;33(32):8167-76. doi: 10.1016/j.biomaterials.2012.07.046. Epub 2012 Aug 11.
9
Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.辣椒素前药胶束共递送紫杉醇促进乳腺癌联合治疗。
Mol Pharm. 2019 Aug 5;16(8):3430-3440. doi: 10.1021/acs.molpharmaceut.9b00209. Epub 2019 Jun 28.
10
Synergistic tumor microenvironment targeting and blood-brain barrier penetration via a pH-responsive dual-ligand strategy for enhanced breast cancer and brain metastasis therapy.通过 pH 响应性双配体策略协同靶向肿瘤微环境和穿透血脑屏障,增强乳腺癌和脑转移的治疗效果。
Nanomedicine. 2018 Aug;14(6):1833-1843. doi: 10.1016/j.nano.2018.05.008. Epub 2018 May 22.

引用本文的文献

1
Current perspectives and global trends of nanotechnology in advanced breast cancer: a bibliometric and visualized analysis.纳米技术在晚期乳腺癌中的当前观点与全球趋势:一项文献计量学与可视化分析
Discov Oncol. 2025 Aug 29;16(1):1652. doi: 10.1007/s12672-025-03260-1.
2
Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases.用于治疗脑转移瘤的纳米颗粒的临床前和临床试验概述。
Pharmaceutics. 2025 Jul 11;17(7):899. doi: 10.3390/pharmaceutics17070899.
3
"Nano-Paclitaxel" Unlocking Potential and Redefining Cancer Chemotherapy.

本文引用的文献

1
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.在 HER2CLIMB 试验中,曲妥珠单抗联合卡培他滨治疗既往治疗的 HER2 阳性乳腺癌伴脑转移的颅内疗效和生存。
J Clin Oncol. 2020 Aug 10;38(23):2610-2619. doi: 10.1200/JCO.20.00775. Epub 2020 May 29.
2
Angiopep-2 Modified Cationic Lipid-Poly-Lactic-Co-Glycolic Acid Delivery Temozolomide and DNA Repair Inhibitor Dbait to Achieve Synergetic Chemo-Radiotherapy Against Glioma.载有替莫唑胺和 DNA 修复抑制剂 Dbait 的 Angiopep-2 修饰阳离子脂质体-聚乳酸-羟基乙酸共聚物递药系统实现协同放化疗治疗脑胶质瘤。
J Nanosci Nanotechnol. 2019 Dec 1;19(12):7539-7545. doi: 10.1166/jnn.2019.16775.
3
“纳米紫杉醇”:释放潜能,重新定义癌症化疗
ACS Omega. 2025 Jun 27;10(27):28670-28690. doi: 10.1021/acsomega.5c02916. eCollection 2025 Jul 15.
4
Deciphering the Blood-Brain Barrier Paradox in Brain Metastasis Development and Therapy.解读脑转移发生发展及治疗过程中的血脑屏障悖论
Cancers (Basel). 2025 Jan 17;17(2):298. doi: 10.3390/cancers17020298.
5
Metastatic brain tumors: from development to cutting-edge treatment.转移性脑肿瘤:从发展到前沿治疗
MedComm (2020). 2024 Dec 20;6(1):e70020. doi: 10.1002/mco2.70020. eCollection 2025 Jan.
6
Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis.已发表的文献:癌症治疗与诊断中的叶酸受体介导转运体
Chem Sci. 2024 Jan 17;15(6):1966-2006. doi: 10.1039/d3sc05539f. eCollection 2024 Feb 7.
7
The Role of Microglia in Brain Metastases: Mechanisms and Strategies.小胶质细胞在脑转移中的作用:机制与策略。
Aging Dis. 2024 Feb 1;15(1):169-185. doi: 10.14336/AD.2023.0514.
8
Metastatic Breast Cancer: Review of Emerging Nanotherapeutics.转移性乳腺癌:新兴纳米疗法综述
Cancers (Basel). 2023 May 25;15(11):2906. doi: 10.3390/cancers15112906.
9
Combination of radiotherapy and targeted therapy for HER2-positive breast cancer brain metastases.曲妥珠单抗联合放疗和抗 HER2 靶向治疗 HER2 阳性乳腺癌脑转移
Eur J Med Res. 2023 Jan 16;28(1):27. doi: 10.1186/s40001-022-00894-7.
10
Molecular signaling network and therapeutic developments in breast cancer brain metastasis.乳腺癌脑转移中的分子信号网络与治疗进展
Adv Cancer Biol Metastasis. 2023 Jul;7:100079. doi: 10.1016/j.adcanc.2022.100079.
Preparation and characterization of angiopep-2 functionalized Ginsenoside-Rg3 loaded nanoparticles and the effect on C6 Glioma cells.制备及鉴定载姜黄素纳米粒并研究其对 C6 胶质瘤细胞的影响
Pharm Dev Technol. 2020 Mar;25(3):385-395. doi: 10.1080/10837450.2018.1551901. Epub 2019 Dec 25.
4
Angiopep-2 modified PEGylated 2-methoxyestradiol micelles to treat the PC12 cells with oxygen-glucose deprivation/reoxygenation.载 Angiopep-2 的聚乙二醇化 2-甲氧基雌二醇胶束治疗氧葡萄糖剥夺/复氧损伤的 PC12 细胞。
Colloids Surf B Biointerfaces. 2018 Nov 1;171:638-646. doi: 10.1016/j.colsurfb.2018.08.009. Epub 2018 Aug 8.
5
Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.载有抗 Angiopep-2 和 CD133 抗体的双靶向免疫脂质体用于神经胶质瘤干细胞。
J Control Release. 2018 Jan 10;269:245-257. doi: 10.1016/j.jconrel.2017.11.026. Epub 2017 Nov 21.
6
Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases.血脑屏障完整性对脑转移瘤生长和治疗反应的影响。
Clin Cancer Res. 2016 Dec 15;22(24):6078-6087. doi: 10.1158/1078-0432.CCR-16-1327. Epub 2016 Aug 12.
7
Progress and perspectives on targeting nanoparticles for brain drug delivery.用于脑药物递送的靶向纳米颗粒的研究进展与展望
Acta Pharm Sin B. 2016 Jul;6(4):268-86. doi: 10.1016/j.apsb.2016.05.013. Epub 2016 Jun 14.
8
A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro.一种新型的拉帕替尼和紫杉醇联合胶束系统,在体外对人表皮生长因子受体2阳性乳腺肿瘤具有增强的抗肿瘤作用。
J Pharm Sci. 2015 Jan;104(1):165-77. doi: 10.1002/jps.24234. Epub 2014 Nov 24.
9
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA.曲妥珠单抗-恩杂鲁胺(T-DM1)对比拉帕替尼加卡培他滨治疗HER2阳性转移性乳腺癌合并中枢神经系统转移患者:EMILIA研究的一项回顾性探索性分析
Ann Oncol. 2015 Jan;26(1):113-119. doi: 10.1093/annonc/mdu486. Epub 2014 Oct 29.
10
Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.靶向肿瘤的双肽修饰阳离子脂质体用于递送 siRNA 和多西紫杉醇至脑胶质瘤。
Biomaterials. 2014 Jun;35(19):5226-39. doi: 10.1016/j.biomaterials.2014.03.017. Epub 2014 Mar 30.